Clinical trial
Safety Study of SRX251 Capsules in Healthy Female Volunteers
NCT00461370 · Azevan Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00461370 |
|---|---|
| Title | Safety Study of SRX251 Capsules in Healthy Female Volunteers |
| Official title | Phase I, Double-Blind, Placebo-Controlled, Ascending, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of SRX251 Capsules in Healthy Female Volunteers |
| Acronym | AVN001 |
| Lead sponsor | Azevan Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | SRX251 |
| Enrollment | 77 |
| Start date | Apr 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Apr 18, 2007 |
| Last update posted | Mar 13, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: